OTCMKTS:CLIGF Clinigen Group (CLIGF) Stock Forecast, Price & News $8.02 0.00 (0.00%) (As of 03/24/2023) Add Compare Share Share Today's Range$8.02▼$8.0250-Day Range$8.02▼$8.0252-Week Range$8.02▼$11.56VolumeN/AAverage Volume8,620 shsMarket Capitalization$1.07 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About Clinigen Group (OTCMKTS:CLIGF) StockClinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.Read More Receive CLIGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clinigen Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CLIGF Stock News HeadlinesMay 11, 2023 | nj.comThe Gen Z Cliff: Why student loan debt and high cost of living has them stressed tf outApril 2, 2023 | americanbankingnews.comFinancial Survey: Nihon Kohden (OTCMKTS:NHNKY) vs. Clinigen Group (OTCMKTS:CLIGF)June 8, 2023 | Stansberry Research (Ad)Bank Collapse Causes Gold Prices to SoarSilicon Valley Bank was the second-largest bank in American history to fail, and investors have started piling into the safety and security of gold. But if you're not taking advantage of a little-known way to invest for around $5 today, you're missing out.March 20, 2023 | forbes.comThe 'Glass Cliff' Phenomenon That Senior Female Leaders Face Today And How To Avoid ItFebruary 28, 2023 | msn.comOak Cliff apartment project will bring affordable unitsFebruary 7, 2023 | msn.comClif Bar CEO, Other Executives To Exit In Wake Of Its Nearly $3 Billion Sale To MondelezNovember 30, 2022 | msn.comLuxury, multi-million-dollar home sale breaks record for Cliffs communitiesOctober 17, 2022 | mirror.co.ukCouple left 'physically shaking' after winning £2.5 million cliff-top home in a raffleJune 8, 2023 | Behind the Markets (Ad)Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software"Denver firm proves its possible to use AI to save the lives of soldiers in combat. England, Germany, Japan and Australia have all signed contracts within the past 18 months. Get the name of the stock here >>>October 6, 2022 | reuters.comCate Blanchett on film 'TÁR': 'We were standing on the edge of a cliff every day'October 6, 2022 | msn.comCliff rescue in double migrant tragedy off GreeceSeptember 19, 2022 | dallasnews.com17-year-old behind bars in fatal shooting at central Oak Cliff gas stationJanuary 17, 2022 | finance.yahoo.comTriton Sweetens Clinigen Bid to Persuade Biggest InvestorsJanuary 12, 2022 | finance.yahoo.comTriton’s Clinigen Bid Wins Support From Proxy Advisory FirmsDecember 23, 2021 | finance.yahoo.comForm 8.5 (EPT/NON-RI) - Clinigen Group plc - AmendmentDecember 16, 2021 | markets.businessinsider.comOctopus Investments : Form 8.3 - Octopus Investments Clinigen Group plcDecember 14, 2021 | markets.businessinsider.comBlackRock Group : Form 8.3 - Clinigen Group plcDecember 9, 2021 | ca.finance.yahoo.comFORM 8.3 – CLINIGEN GROUP PLCDecember 4, 2021 | au.finance.yahoo.com‘We need a minister for young jobless to tackle school leaver crisis’November 26, 2021 | finance.yahoo.comShareholders in Clinigen Group (LON:CLIN) are in the red if they invested three years agoOctober 15, 2021 | markets.businessinsider.comClinigen Group plc : Annual Financial ReportSeptember 22, 2021 | finance.yahoo.comSecura Bio Announces European Distribution Agreement for COPIKTRA® with Clinigen Healthcare LimitedAugust 21, 2021 | finance.yahoo.comClinigen Group plc's (LON:CLIN) Intrinsic Value Is Potentially 79% Above Its Share PriceJuly 25, 2021 | markets.businessinsider.comClinigen Group plc : Clinigen signs agreement with ORPHELIA PharmaJuly 17, 2021 | markets.businessinsider.comClinigen Group plc : Year End Trading UpdateJuly 16, 2021 | finance.yahoo.comIs The Market Rewarding Clinigen Group plc (LON:CLIN) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?June 10, 2021 | finance.yahoo.comA Look At Clinigen Group's (LON:CLIN) Share Price ReturnsSee More Headlines CLIGF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLIGF Company Calendar Today6/08/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CLIGF Previous SymbolNASDAQ:CLIGF CUSIPN/A CIKN/A Webwww.clinigengroup.com Phone44-12-8349-5010Fax01283 495011Employees1,069Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$704.71 million Price / Sales1.51 Cash Flow$1.43 per share Price / Cash Flow5.60 Book Value$4.52 per share Price / Book1.77Miscellaneous Outstanding Shares133,030,000Free FloatN/AMarket Cap$1.07 billion OptionableNot Optionable Beta0.49 Key ExecutivesMr. Shaun Edward Chilton (Age 54)CEO & Exec. Director Comp: $867.89kRichard PalingInterim Chief Financial Officer & Group Financial ControllerMr. Sam HerbertChief Operating OfficerRob FoxVP of Investor Relations & Corp. Devel.Ms. Amanda MillerGen. Counsel & Company Sec.Mr. David BryantDirector of Corp. Devel.Jessica ArcherGlobal HR DirectorMr. Mark CorbettManaging Director of Global Access DivisionMr. Johannes Willemse (Age 54)Chief Commercial Officer Mr. Ivo Timmermans M.D. (Age 62)MBA, Chief Medial Officer More ExecutivesKey CompetitorsPharma MarOTCMKTS:PHMMFOxford BiomedicaOTCMKTS:OXBDFSemperit AktiengesellschaftOTCMKTS:SEIGYAurora CannabisOTCMKTS:ACBFFZealand Pharma A/SOTCMKTS:ZLDPFView All Competitors CLIGF Stock - Frequently Asked Questions How have CLIGF shares performed in 2023? Clinigen Group's stock was trading at $8.0157 at the start of the year. Since then, CLIGF shares have increased by 0.0% and is now trading at $8.0157. View the best growth stocks for 2023 here. What is Clinigen Group's stock symbol? Clinigen Group trades on the OTCMKTS under the ticker symbol "CLIGF." How do I buy shares of Clinigen Group? Shares of CLIGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Clinigen Group's stock price today? One share of CLIGF stock can currently be purchased for approximately $8.02. How much money does Clinigen Group make? Clinigen Group (OTCMKTS:CLIGF) has a market capitalization of $1.07 billion and generates $704.71 million in revenue each year. How many employees does Clinigen Group have? The company employs 1,069 workers across the globe. How can I contact Clinigen Group? Clinigen Group's mailing address is PITCAIRN HOUSE CROWN SQUARE FIRST AVENUE, Burton-on-Trent X0, DE14 2WW. The official website for the company is www.clinigengroup.com. The company can be reached via phone at 44-12-8349-5010 or via fax at 01283 495011. This page (OTCMKTS:CLIGF) was last updated on 6/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clinigen Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.